{"ticker": "BM", "text": "\n\n\n\nIndia's largest private lender ICICI Bank Ltd., cigarrete maker ITC Ltd., drug manufacuturer Dr. Reddy's Laboratories Ltd. and the biggest passenger carmaker of the country Maruti Suzuki Ltd. are among the companies reporting their financial results for the April-June period on Thursday.ICICI Bank Ltd. is likely to see another quarter of muted earnings with an over 10 percent decline in net profit on a year-on-year basis, according to Bloomberg consensus estimate. The bank\u2019s core income from operations is estimated to grow 11.8 percent compared to last year. The Chanda Kocchar-led lender is also expected to see its asset quality, already at its worst in a decade, deteriorate further.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nMovement of watch-list accounts and slippages outside the watchlist.Outlook on asset quality.The provision requirement for accounts referred to the Insolvency and Bankruptcy CodeCommentary on growth and marginsStake sale in subsidiaries.\n\n\n\n\n\n\nMaruti Suzuki Ltd.'s profit in the April-June quarter is expected to grow 13.7 percent over last year to Rs 1,690 crore, according to Bloomberg consensus estimate. The topline will likely be aided by a 13 percent sales growth. Operating margin is expected to contract to 14.3 percent from 17 percent due to fixed costs related to the carmaker's manufacturing plant in Gujarat. Compensation offered to dealers for the newly implemented Goods and Services Tax is also expected to impact profit growth.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nUpdate on channel inventory, discounting trends and new launchesGujarat plant product pipelineImpact of GST on demand\n\n\n\n\n\n\nOil and Natural Gas Corporation Ltd. may see its earnings before interest, tax, depreciation and amortisation double to Rs 9,235 crore on a year-on-year basis. The operating margin too is seen expanding over 20 percentage points to 42 percent, according to Bloomberg consensus estimates. The explorer may realise a price of $51 for every barrel of oil.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nManagement commentary on HPCL buyoutDevelopment plans for KG basinOutlook on gas pricesOutlook on oil production volumes\n\n\n\n\n\n\nDr. Reddy's Laboratories may see net profit more than double to Rs 304 crore, according to Bloomberg consensus estimate. Operating income may grow 65 percent to Rs 644 crore, while operating margin may expand over 600 basis points to 18.7 percent. The drugmaker is expected to report flat growth in North America, but Europe is expected to grow 25 percent over last year. India business is seen declining 10 percent year-on-year.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nNew launchesExpect strong constant currency growth in Russia due to Rituximab launchRemediation at plants to impact marginsQ1FY18 is a seasonally soft quarter for Dr Reddy\u2019s margin\n\n\n\n\n\n\nITC Ltd. is expected to report a 10.1 percent profit growth and a 4 percent sales growth over last year. Volume of cigarette sales is expected to decline 2-3 percent, while the fast moving consumer goods business is likely to see a subdued quarter. The operating margin is expected to narrow slightly to 34.9 percent.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nDestocking likely to impact canteen store salesSustained weakness in paper businessAgri business to see pressure owing on high baseHotel business revenue to remain flat\n\n\n\n\n\n\nOther Results\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nDeal closuresProgress on digital and platform related businessesIncremental revenues from geometric integrationRupee appreciation impact on marginsCommentary on telecom business\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nUpdate on Vodafone-Idea mergerManagement commentary on strategy to tackle subscriber churn to Reliance JioInterventions to revive industryPlans to launch more unlimited bundled plansAverage revenue per user guidance\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nStrattera & Zetia to drive the quarter for GlenmarkCompany will book remaining two months of Zetia exclusivity sales in 1QExpect close to $50 million to be booked for Zetia in Q1Latin America would be impacted due to currency depreciationExpect the impact of GST disruptions to be low relatively to peers\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nMuted Syngene and weak biopharma sales to impact revenues of the companyOngoing operational expenses at its Malaysian insulin facility to impact costsCosts at Malaysian facility till now were being capitalisedRemediation costs at Bangalore to impact margins\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat To Watch\n\n\n\n\n\n\nUpdate on demand environment for OEMs, auto replacementMarket share in autos and non-autos.Outlook for raw material cost trend, recent pricing action\n\n\n\n", "title": "\n\n\n        Earnings Today: Biocon, Maruti Suzuki, ICICI Bank, ONGC\n      \n\n", "time": "2017-07-27 02:08:00"}